Rhythm Pharmaceuticals Inc (1RV F) stock market data APIs
€84.775
3.13(3.7%)
as of December 4, 2025
Try our APIs with
free plan!
Rhythm Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.
Prev. Close
84.775
Open
87.903
High
87.9123
Low
83.8224
52 wk Range
41-98.5
Market Cap
5 778 M
Shares Outstanding
66 736 K
Revenue
174 M
EPS
-0.82
Beta
1.96
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rhythm Pharmaceuticals Inc data using free add-ons & libraries
Get Rhythm Pharmaceuticals Inc Fundamental Data
Rhythm Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 174 M
- EBITDA: -184 759 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: -0.73
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rhythm Pharmaceuticals Inc News
New
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.
RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking to make deals. Continue Reading
Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
3 Prominent Stocks Estimated To Be Up To 35.1% Below Intrinsic Value
As the U.S. stock market shows signs of recovery with major indexes snapping recent losing streaks, investors are keeping a close watch on tech giants like Nvidia for insights into broader market tren...
Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025
Rhythm Pharmaceuticals, Inc. – Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic obesity on concomitant treatment with GLP...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
